) and Affimed Therapeutics  AG (Heidelberg, Germany, 

) have signed a cross-license  and collaboration agreement for antibody-related technologies. The agreement  provides XOMA with a license under Affimed’s antibody library patents for  antibody discovery purposes, as well as for the development and  commercialization of antibodies.

News

XOMA Ltd. (Berkeley, CA, http://www.xoma.com) and Affimed Therapeutics AG (Heidelberg, Germany, www.affimed.com) have signed a cross-license and collaboration agreement for antibody-related technologies.